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Seasonality of disease, mainly of respiratory pathogens, is a key
feature [1]. The Middle East Respiratory Syndrome Coronavirus
(MERS-CoV) is a newly emerging respiratory viral infection and causes
asymptomatic or mild infection and may result in a life threatening
disease with a high case fatality rate. As reported by the World Health
Organization, the virus caused a total of 2143 laboratory-confirmed
cases from 27 countries, including 750 (35%) deaths. It is important to
understand the transmission of the virus and the occurence of any
seasonal variation in the transmission between humans and animals.
Based on the occurence of initial clusters in April 2012, April–May
2013, and May 2014, it was concluded that there was a significant
MERS-CoV activity in March–May of each year. Initial hospital out-
breaks also occurred in April 2012 (Zarqa public health hospital,
Jordan), April–May 2013 (Al-Hasa Outbreak) and April–May 2014
(Jeddah outbreak). Thus, it was thought that MERS-CoV occurs pre-
dominantly during the spring (March–May). The occurrence of cases in
the spring raises the possibility of seasonal cycles of MERS-CoV as ca-
mels give birth in March (spring) and MERS-CoV occurs commonly in
young camels. Seasonal variation may reflect the risk of transmission of
MERS-CoV between animals and humans. Here, we analyze publicly
available MERS-CoV data to evaluate any seasonal variation of MERS-
CoV. We retrospectively analyzed reported cases between January 2013
and December 2017. We reviewed all reported MERS-CoV cases from
the Saudi Ministry of Health website and the World Health Organiza-
tion [2,3]. Primary cases were considered when the cases were not
linked to other cases in the community or in healthcare settings.
The analysis included seasonal variation and monthly variation over
the included years. Statistical analysis was done using Minitab®
(Minitab Inc. Version 17. PA 16801, USA; 2017). A time-trend analysis
was used to generate a linear trend for the monthly distribution and
then for seasonal distribution of the cases. We generated a forecasting
of primary MERS-CoV cases over time and exteneded this for an addi-
tional six seasons. We then used the moving average plot of primary
MERS-CoV cases with forecast in relation to the seasons for an addi-
tional four seasons. A significant P value was considered for p < 0.05.
We also used the classic multiplicative time series in order to decom-
pose the original data into seasonal, irregular and trend component and
obtained the effects.
A total of 2025 cases were reported to the World Health
Organization. All cases were confirmed MERS-CoV. However, it was
only possible to classify cases as primary or secondary cases from
January 2015 onwards. Thus, further analysis of seasonality was done
on cases reported in 2015–2017.
There was an overall negative trend and reduction in the monthly
number of primary MERS-CoV cases between 2015 and 2017 (Fig. 1)
with a regression analysis showing P value of 0.023. The curve of case
numbers clearly shows some peaks and significant variations overtime.
These peaks do not appear to follow a seasonal pattern (no clear rela-
tion with months). However, these variations may be due to climatic
factors, like temperature or hygrometry. Seasonal analysis of the data
showed an initial increase in number of cases in the winter and the
summer of 2015, a lower number of cases in 2016 and a higher number
of cases in the winter of 2017. Although, taking all the cases together
the majority of cases occurred in the winter (33%), the summer (27.4%)
and the fall (21.4%). Using trend analysis and forecasting into the fu-
ture, the analysis showed that primary MERS-CoV cases would be about
5 cases in the spring of 2019.
Decomposition of the MERS-CoV cases using the centered moving
average showed that August 2015 rate was 83% above the average, and
that summer 2015 and winter 2017 were 40% and 31% above the
moving average.
Since the emergence of MERS-CoV infection in 2012, there was an
increase in the annual number of MERS-CoV cases in 2014 and 2015
with subsequent reduction in the cases in the following two years.
Seasonal variations among the transmission of respiratory viruses
reflect the risk of animal-human transmission, difference in the circu-
lating viruses, and the natural reservoirs of specific viruses [4]. Since
the emergence of MERS-CoV, it was though that MERS-CoV transmis-
sion occurs through two seasons: the spring (March–May) and the fall
(September-November) [5]. Seasonal variation may occur due to dro-
medaries’ calving season (November and March). In one study, the
prevalence of MERS-CoV was higher among camels in the winter time
(71.5%) than the summer time (6.2%) [6].
In an analysis of MERS-CoV cases from June 2012 to July 2016,
authors estimated mean monthly data for all the included studies and
showed that MERS-CoV may have two peaks in the winter and summer
months [7]. However, we showed no definite seasonal variation of
primary MERS-CoV cases despite initial peak in February and August
2015 and in March 2017. Our analysis is different as we relied on
primary MERS-CoV cases. It is important to keep in mind that 37.5% of
reported cases are related to health care-associated infections, 16%
were secondary to contact with an infected family member and 8.2%
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had no identified risk factors. Thus, focusing on primary cases only to
understand transmission pathways might be insufficient. Since me-
chanisms underlying secondary transmission can be dependent on en-
vironmental factors potentially associated with climate and season
parameters. Seasonal variation may also reflect more effective trans-
mission during certain periods of the year due to hygrometry and am-
bient temperature as shown for influenza virus transmission. In con-
clusion, we did not observe any seasonality in the occurrence of MERS.
There were higher numbers of cases in the winter and the summer of
2015 and the spring of 2017. Any seasonal variation may reflect cyclic
variation in the circulation of MERS-CoV in animals or the variation in
the human-camel interactions as people became aware of this connec-
tion. It is important to note that healthcare associated transmissions of
MERS-CoV is the hall mark of MERS disease [5].
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Fig. 1. Monthly distribution and time trends of Primary MERS-CoV cases with the Index (X-axis) representing January 2015 to December 2017.
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